



Abstract— Damage to peripheral nerve fibers results in 
axonal loss and demyelination followed by regeneration and 
remyelination under optimal conditions with the possibility of 
some functional recovery. The experimental challenge is to 
accelerate axonal regeneration to promote reinnervation and 
improve functional recovery after peripheral nerve injury. In 
the past few decades, different types of biological or artificial 
guide tubes have been developed to bridge the gap of a 
sectioned nerve, to limit the fibrosis process and to orient the 
regenerating fibers towards the distal stump. Chitosan is widely 
used for biomedical applications, including crosslinked with 
other materials. In this work, chitosan guide tubes were 
produced and implanted using the rat sciatic nerve animal 
model. Functional tests were performed as well as a mechanical 
and structural characterization of the guide tubes. 
I. INTRODUCTION 
It is estimated that about 2.8% of trauma patients, many 
of whom have acquired life-long disabilities, are affected by 
peripheral nerve injuries. Unlike what happens in the central 
nervous system of mammals, the peripheral nervous system 
has a permissive environment provided by the Schwann 
cells[1][2]. Peripheral nerve injuries may include or not gaps 
between the nerve stumps. If an intervention is not made after 
an injury occurs, functional regeneration becomes restricted 
due to scars, neuroma formation or mismatched fibers[3]. In 
neurotmesis injuries, the nerve is completely transected. 
Without a surgical reconstruction the axonal regrowth is 
impossible, making this the most challenging type of 
peripheral nerve injury repair[4]. The tissue engineering 
approach is to repair, complement and regenerate damaged 
tissue by using materials that will support and reinforce the 
regenerating tissue. One of the strategies is to build three-
dimensional, porous scaffolds which role is to manipulate 
cell functions since they provide spaces and surface area 
enough for cell adhesion and proliferation, and to supply 
oxygen and nourishment. These scaffolds should be 
biocompatible and biodegradable, have a large surface to 
volume ratio, and be mechanically strong and capable of 
being formed into desired shapes and structures[5]. 
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II. CHITOSAN 
Chitosan is a natural and hydrophilic copolymer of D-
glucosamine and N-acetylglucosamine units and it is 
obtained from full or partial N-deacetylation of chitin. Its 
biodegradability, biocompatibility, nonantigenicity, 
promotion of cell adhesion and nontoxicity has made it 
possible to use chitosan in a number of biomedical 
applications[6]. Being fragile in the dried form, chitosan can 
be chemically crosslinked or jointly used with other materials 
before scaffold fabrication. Chitosan matrices have low 
mechanical strength under physiological conditions and are 
unable to maintain a predefined shape after 
transplantation[7]. Their mechanical properties can be 
improved by adding γ -glycidoxypropyltrimethoxysilane 
(GPTMS) as a crosslinker, which is a silane coupling-agent 
with epoxy and methoxysilane groups. This modification, 
along with a freeze-drying technique, has been shown to 
produce chitosan type III membranes with 90% porosity and 
successful improvement of rat sciatic nerve regeneration after 
axonotmesis. It was concluded that this material, apart from 
working as a simple mechanical scaffold, could also work as 
an inducer of nerve regeneration[8][9]. 
The goals established for this work were to prepare 
chitosan guide tubes crosslinked with GPTMS, to 
mechanically and structurally characterize them, and finally 
to implant them in a group of animals. This would allow to 
compare the obtained results with others already described 
and published and to assess if improvements were achieved. 
III. MATERIALS AND METHODS 
Both chitosan (degree of deacetylation >75%; Sigma-
Aldrich®, USA) and GPTMS (Sigma-Aldrich®, USA) were 
dissolved separately in a 0.25 M acetic acid solution in order 
to attain a concentration of 2% (w/v) and 27.7% (w/v), 
respectively. For the crosslinking to occur, the GPTMS 
solution was added to the chitosan solution to obtain a molar 
ratio of 1:0.5 (chitosan:GPTMS). The resultant chitosan-
GPTMS solution was poured into teflon molds, frozen at -
20oC and then lyophilized to complete dryness. The resultant 
guide tubes were soaked in a 0.1 M NaOH aqueous solution 
to neutralize remaining residues of acetic acid and then 
lyophilized once again. The morphology and microstructure 
of the chitosan-GPTMS guide tubes were analyzed under a 
scanning electron microscope (SEM) with an accelerating 
voltage of 5 kV. The guide tubes and chitosan powder were 
characterized by Fourier Transform Infrared (FTIR) 
spectroscopy. Sixty-four scans were performed with a 
resolution of 4 cm-1. To evaluate the water uptake of the 
guide tubes, the samples were soaked in a phosphate-buffered 
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saline (PBS) solution at pH 7.4 at 37oC during 7 days. The 
water uptake was calculated using Equation (1) where Ww is 
the weight of the wet guide tubes and Wd is the weight of the 
dry guide tubes. The degree of crosslinking (DC) of the guide 
tubes was determined by the ninhydrin (NHN) assay, which 
determines the percentage of free amino groups (NH2) 
remaining in the guide tubes after crosslinking, according to a 
method previously described in the literature[10]. The 
mechanical behavior of the guide tubes was evaluated and 
stress-strain curves were obtained for both dry and hydrated 
samples. Strip-shaped membranes were stretched using a 
crosshead speed of 1 mm/min. Young’s modulus, i.e. the 
elastic modulus, was calculated from the stress at break and 
the strain at break. 
In vivo testing was performed in four adult male Saco 
Sprague Dawley rats on which was inflicted a neurotmesis 
injury in the right sciatic nerve surgically reconstructed with 
a crosslinked chitosan guide tube. For the functional 
assessment, all animals were tested pre-operatively (week 0), 
at week 1 and every two weeks after the surgery, for a total 
period of follow-up of 20 weeks.1 Motor performance and 
nociceptive function were evaluated by measuring extensor 
postural thrust (EPT) and withdrawal reflex latency (WRL), 
respectively. In the first test, the force applied by the rat in 
grams was recorded, for both the healthy and affected 
hindlimb. The normal EPT (NEPT) (regarding the healthy 
hindlimb) and the experimental EPT (EEPT) values were 
used in Equation (3) to derive the percentage of functional 
deficit. The second test, called the hotplate test, consisted of 
placing the healthy hind paw of the rat in a plate at 56oC and 
measuring the time elapsed until its withdrawal. The same 
was performed for the affected hind paw. If there was no hind 
paw withdrawal after 12 seconds, the heat stimulus would be 
ceased in order to prevent tissue damage. For sciatic 
functional index (SFI), the animals were tested in a confined 
walkway where they were put to walk in order to get their 
footprints on paper. Some measurements were taken such as 
the distance from the heel to the third toe (print length)(PL); 
the distance from the first to the fifth toe (toe spread)(TS); 
and the distance from the second to the fourth toe 
(intermediary toe spread)(ITS). For both dynamic (SFI) and 
static assessment (SSI) all measurements were taken from the 
experimental (E) and normal (N) hindlimbs. Concerning SFI 
and SSI, an index of 0 is considered normal and an index of -
100 indicates total impairment. All the results obtained for 
this group of four animals were then compared to those of 
other experimental groups. In control group none of the 
animals had a sciatic nerve injury; in gap group the injured 
nerve was left without any repair intervention; in end-to-end 
group immediate coaptation with epineurial sutures of the 
two transected nerve stumps was performed; in graft group it 
was obtained a nerve graft from the animal itself which was 
inverted 180o and then sutured; in PLGA group a poly(L-
lactic-co-glycolic acid) (PLGA) guide tube was sutured to a 
transected sciatic nerve. Opposite leg and sciatic nerve were 
left intact in all groups and served as control for normal 
nerves. 
 
1 At the time of the thesis submission, it was only possible to perform the 
functional tests up until the fourth week. 
IV. RESULTS 
Fig. 1 shows the microstructure of the chitosan-GPTMS 
guide tubes, which are highly porous. This is in accordance 
with previous studies where investigators obtained chitosan-
GPTMS membranes with a porosity of 90% and 110 µm 
pores[5]. 
 
Figure 1. SEM images of the chitosan-GPTMS guide tubes. 
 
In the FTIR spectrum of chitosan (Fig. 2) the bands 
around 1650 cm-1 and 1565 cm-1 are attributed to the amine 
bands I and II, respectively[11]. The reaction between amine 
groups present in chitosan and oxirane groups in GPTMS can 
be located in the transmittance band at 1550 cm-1. 
The water uptake of the chitosan-GPTMS guide tubes 
was evaluated during 7 days. In the first two hours, they 
quickly absorbed the fluids being the water uptake nearly 
1000% of the initial dry mass. However, after 24 hours this 
value started to decreased which may be due to mass loss. 
As mentioned before, GPTMS was used as a crosslinker 
in the preparation of the guide tubes. Their degree of 
crosslinking was around 69%. 
Stress-strain curves were plotted and Young’s modulus 
(E) was calculated for both dry and hydrated samples at a 
fixed strain of 2%. It was observed an increase in the stress 
with increasing strain until material collapse occurred. 
Hydrated samples presented ultimate tensile stress lower than 
that of dry samples (0.02±0.02 and 0.18±0.08 MPa, 
respectively) due to the amount of water that filled the porous 
structure. Water might also work as a plasticizer agent, 
leading to a decrease of the Young’s modulus from 
2.91±2.20 MPa for the dry samples to 0.19±0.05 MPa for the 
hydrated samples. 
 
Figure 2. FTIR spectrum of chitosan-GPTMS (A) and chitosan powder (B). 
  
 
The results of the motor deficit (Fig. 3) showed that nerve 
transection (neurotmesis) caused a severe motor deficit in all 
experimental groups except in control group. One week after 
the intervention, the five groups severe loss of hindlimb 
extension force. During the follow-up period of 20 weeks, it 
can be observed that the motor deficit decreases, with a faster 
recovery along time in some groups than in others. However, 
in the chitosan-GPTMS (Ch-GPTMS) group there is no 
evidence of motor deficit decrease since the results 
concerning this group only go as far as week 4 post-surgery. 
Fig. 3 also shows the result for the WRL test. In the first 
week post-surgery, all animals presented severe loss of 
sensory function and all tests had to be interrupted at the 
selected cutoff time of 12 seconds except for control group. 
Throughout the follow-up time the nociception function was 
recovered and at week 20 it was in the range of normal values 
(bellow 4.3 seconds) except for gap group, which did not 
present any recovery of the WRL, since the neurotmesis 
injury was not surgically repaired. The Ch-GPTMS group 
was already showing some decrease of the WRL at week 4. 
At the end of the 20 weeks, the results of the hotplate test 
were similar in all four experimental treated groups. Gap 
group showed no signs of recovery in sensory function. 
Both SFI and SSI were evaluated only in a small number 
of animals and not for all the experimental groups. At week 0 
(pre-operative) SFI was -7.4±5.4 in the gap group. One week 
after surgeries, SFI was -83.2±2.2 for graft group. This 
results indicates a profound impairment in foot and toes 
ground contact. By the end of the follow-up period, SFI 
values remained highly negative which indicated only a 
modest recovery of the foot placement after neurotmesis. At 
week 20, the PLGA group had a SFI value of -62.3±2.3 and 
for the gap group -82.5±4.3[12]. Variations on the SSI results 
were similar to SFI’s. By week 20, SSI values were -76.6±4.9 
for the gap group. For the Ch-GPTMS group SFI was -
55.2±0.0 in both week 1 and week 2 post-operative. At week 
4, SFI became even more negative which translates the great 
impairment in foot and toes ground contact. It was verified in 
almost experimental rats autotomy, which limits the SFI test 
evaluation. 
 
Figure 3. EPT and WRL results for 20 weeks follow-up. 
 
V. DISCUSSION 
In the present study, chitosan-GPTMS guide tubes were 
produced and a number of assays were performed in order to 
characterize them mechanically and structurally. Also, in vivo 
testing took place using the rat sciatic nerve as the 
experimental model. Peripheral nerve regeneration was 
assessed after a neurotmesis injury was induced. 
The FTIR spectrum provides information through band 
properties, frequencies and intensities and it can be used to 
predict chemical processes and identify species[11]. The 
2840 cm-1 peak is assigned to the methoxy group of the 
GPTMS and the 1192 and 914 cm-1 peaks are assigned to the 
epoxy group, which shows the presence of the crosslinker in 
the guide tubes[13]. 
The ninhydrin reaction determined quantitatively the 
amount of free amino groups, thus calculating the DC of the 
chitosan-GPTMS guide tubes. Of all the cyclic units of 
chitosan, 79% of them has an amino group that force-opens 
the epoxy group of GPTMS to form a –NH-O- bond[5]. 
During the crosslinking reaction, the epoxy group is linked to 
the amino group of chitosan and the methoxysilane groups 
are hydrolyzed forming silanol groups. These are subjected to 
the construction of a siloxane network due to condensation. 
Furthermore, the negative charges of the silanol groups and 
the positive charges of the amino groups favor the 
crosslinking reaction[13]. 
Observing Fig. 1, it becomes clear that the chitosan-
GPTMS guide tubes are highly porous, which in some extent 
is due to the presence of GPTMS that has been shown to be 
responsible for the size of the pores. Also, the pore size is 
strongly dependent on the freezing temperature, being that 
the size increased with the freezing temperature[5]. The 
guide tubes were developed in order to be porous while 
preserving some mechanical strength, which is a factor to be 
considered in order to avoid problems during transplantation 
and healing period such as collapsing and disintegration. The 
balance between hardness and flexibility should also be taken 
into account[14]. Concerning the mechanical test, the 
hydrated samples had a lower Young’s modulus, which 
means that when in an environment with fluids, the guide 
tubes are less rigid and brittle. Thus, they become more prone 
to collapse than when dry. 
During the period of swelling, the porous structures were 
filled with PBS and can go through a degradation process. At 
this point, the water occupies the atomic level space in the 
matrix as well as the pores. This demonstrates the ability of 
the matrix of the guide tubes to hold water, which is higher 
than the ability of the original chitosan[8]. These 
observations can be correlated with the SEM images, 
confirming the high values of water uptake. 
The rat sciatic nerve has been the most commonly used 
animal model for studies concerning peripheral nerve 
regeneration due to its reliability[15]. Both functional and 
morphological assessments are evaluation tools when it is 
important to quantify the regeneration of the peripheral nerve 
considering different therapeutic strategies. Chitosan-
GPTMS structures have shown in in vivo studies an improved 
  
nerve fiber regeneration and functional recovery in 
neurotmesis injuries. The EPT and WRL tests have been 
proven to be reliable, valid and highly efficient tests when it 
comes to determine the functional recovery following sciatic 
nerve injury. They also provide a quantitative measurement 
of motor and sensitive function recoveries, respectively, and 
give consistently less variation between measurements. SFI 
tests provide a quantitative measure of degree of functional 
deficit, but can be cumbersome, time consuming and 
variable, especially considering the evaluation of neurotmesis 
injuries recoveries[16]. 
The surgeries allowed evaluating the performance of the 
chitosan-GPTMS guide tubes when in contact with fluids. 
The main observation was their friability which in some way 
is consistent with what was previously mentioned about the 
porosity, water uptake and mechanical strength. However, 
their mechanical behavior can be improved if an optimal ratio 
is achieved between chitosan and the crosslinker. 
VI. CONCLUSION 
The goals initially proposed for this experimental work 
were accomplished. From the mechanical and structural 
analysis, the chitosan-GPTMS guide tubes seem to be 
suitable and in some way ideal to promote the nerve 
regeneration after a neurotmesis injury. However, the 
process of preparation of the guide tubes has yet alterations 
and improvements to be made in order to reach optimal 
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